|Title:||Possible ways of pharmacological correction of ischemic damage to the liver with the agonist of peripheral imidazoline receptors C7070|
|Authors:||Dovgan, A. P.|
Urojevskaya, J. S.
Khavansky, A. V.
imidazoline receptor agonists
|Citation:||Dovgan, A.P. Possible ways of pharmacological correction of ischemic damage to the liver with the agonist of peripheral imidazoline receptors C7070 / A.P. Dovgan, J.S. Urojevskaya, A.V. Khavansky // Research result. Pharmacology and clinical pharmacology. - 2017. - Vol.3, №3.-P. 3-8. - DOI: 10.18413/2313-8971-2017-3-3-3-8.|
|Abstract:||We glad to introduce several variants of pharmacological correction of ischemic hepatic injury by imidazoline I2 receptor agonist С7070. Materials and methods: The experiment was carried out on 70 rats of both sexes, divided into 7 groups (n = 10). The indicated agonists of peripheral imidazoline I2receptors (C7070) significantly reducesischemically-reperfusion injury of the liver, in comparison with the preparations of moxonidine and metformine. Indirect sign of imidazoline activating mechanism of C7070 is decreasing of the hepatoprotective effect of C7070 by the preliminary administration of imidazoline receptor blocker BU-224|
|Appears in Collections:||Research Result. Pharmacology and Clinical Pharmacology|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.